Information  X 
Enter a valid email address

ImmundiagnosticSysHldngsPLC 2P (IDH)

Related News

23-Jul-2020 08:53 AM

Immunodiagnostic Systems sees signs of recovery after revenue slumps in Q1

Immunodiagnostic Systems reported signs of a recovery in performance after revenue plunge in first-quarter revenue owing to the impact of the COVID-19 pandemic. For the 3 months to 30 June, revenue fell to £5.7m from £9.1m on-year and plung
17-Jun-2020 09:09 AM

Immunodiagnostic Systems warns on performance amid fall in laboratory testing volumes

Immunodiagnostic Systems warned its first-quarter results would be 'significantly impacted' by reduced laboratory testing volumes owing to the ongoing Covid-19 pandemic. The company said, however, it was in a 'strong position' to con
19-Jun-2019 03:00 PM

Immunodiagnostic Systems posts modest profit as margins shrink

Immunodiagnostic Systems Holdings posted a modest annual profit after rising sales were offset by higher R&D and administrative spending. Pre-tax profit for the year through March rose to £842k, down from £935k on-year. Revenue rose 1% to &p
16-Jan-2018 08:24 AM

IDS partnership agreement with Technogenetics

Immunodiagnostic Systems Holdings has reached agreement with Technogenetics srl to enable IDS to sell TGS's range of assay kits under the IDS brand, on a global basis. TGS produces a broad range of CE approved CLIA automated assay kits for use in th
23-Oct-2017 08:28 AM

IDH first half revenues fall

Immunodiagnostic Systems Holdings' first half revenues are 4% down on last year due to a fall in antibody licence income from a large customer which had been expected. It said that unaudited group revenues for the six months to the end of September
10-Aug-2017 02:13 PM

Immunodiagnostic Systems launches IDS-iSYS

Immunodiagnostic Systems has launched the IDS-iSYS Free Testosterone assay in the European market. The Company said it is a fully automated CLIA assay for use with serum and plasma samples on the IDS-iSYS Automated System. The launch of the IDS-iSYS Fre
27-Jul-2017 09:13 AM

IDS like-for-like revenues fall

Immunodiagnostic Systems Holdings' unaudited group revenues rose to £9.7m in the first quarter, 2% higher than a year ago, shareholders at today's annual general meeting will be told. But chairman Dr. Burkhard Wittek will say that on a l
21-Jun-2017 07:18 AM

IDS dividend up 233%

Immunodiagnostic Systems Holdings has declared a dividend of 4.0p per share for the year to theend of March - 233% up on last time. Reported revenues increased by 4% to £40.0m. On a like-for-like basis the revenue decline was 8%. Revenue, exclu
21-Apr-2017 07:18 AM

IDS revenues boosted by weak pound

Immunodiagnostic Systems Holdings expects revenue for the year ended 31 March to be approximately £40m, an increase of around 4% compared to the previous year. It said revenue had been favourably impacted by the weakening of the pound against t
01-Mar-2017 02:39 PM

IDH launches IDS-iSYS InaKtif MGP assay

Immunodiagnostic Systems (IDH) has launched the IDS-iSYS InaKtif MGP assay in the European market. It says this is a fully automated CLIA assay for use with plasma samples on the IDS-iSYS Automated System The Company added: "The launch of the IDS-
21-Oct-2016 07:35 AM

IDS like-for-like revenues fall

Immunodiagnostic Systems Holdings, a specialist producer of manual and automated diagnostic testing kits and instruments for the clinical market, expects first half revenues of £19.5m compared with £19.4m last time. On a like for like basi
28-Jul-2016 08:13 AM

Immunodiagnostic Systems revenue down

Immunodiagnostic Systems said it will hold its AGM today where chairman Dr Burkhard Wittek will make the following statement to shareholders. "Group revenue (unaudited) for Q1 FY2017 is £9.5m, 7% lower than for the same period last year. &quo
22-Jun-2016 07:43 AM

IDS revenues fall

Immunodiagnostic Systems Holding' revenue fell to £38.3m in the year to the end of March (2015: £45.4m) showed a 15.6% decline based on actual exchange rates. Excluding the acquisition of Diametra and at constant exchange rates the decl
25-Apr-2016 07:35 AM

IDS revenues in line with guidance

Immunodiagnostic Systems Holdings expects total revenues for the year ended 31 March to be around GBO39 million - down from GBP45 million last time but in line with the guidance given in November. IDS says the decrease in revenues year on year is mai
04-Jan-2016 07:50 AM

IDS finance director takes up reins

Immunodiagnostic Systems Holdings has announced that Paul Martin has officially joined the board of IDS and taken up his position as group finance director. Story provided by StockMarketWire.com...
24-Nov-2015 09:04 AM

IDS' revenues

Immunodiagnostic Systems Holdings' first half revenues fell to £19.4m - down from £22.1m last time but in line with its trading update on 13 October. Automated revenues (IDS-iSYS) totalled £9.0m (H1 2015: £10.3m) impacted, as previously flagge
13-Oct-2015 07:33 AM

IDS trading environment remains challenging

Immunodiagnostic Systems Holdings expects total revenues for the six months to the end of September to be around £19m - 13% down on last time - and it warns that the near-term trading environment remains challenging Using a constant exchange rate fr
04-Aug-2015 07:45 AM

IDH 'facing a lot of challenges'

Immunodiagnostic Systems Holdings' first quarter was challenging with revenues at the group level down 15%, shareholders at the annual general meeting today will be told. Chairman Dr. Burkhard Wittek will say: "The start to FY 2016 was challen
23-Jun-2015 07:49 AM

IDS revenues fall

Immunodiagnostic Systems Holdings - a leading producer of manual and automated specialist diagnostic testing kits - posts pre-tax profits of £4.05m for the year to the end of March, down from £8.3m last time. Revenue fell to £45.4m - a 13.2% decline
10-Jun-2015 08:03 AM

IDS strengthens its board

Immunodiagnostic Systems Holdings has appointed Peter Williamson as a non-executive director with effect from 15 June. Williamson holds a Master of Business Administration from the University of Edinburgh. Between 1993 and 2010 he worked in various pos
29-May-2015 07:53 AM

IDS in line with guidance

Immunodiagnostic Systems Holdings' revenues for the year that ended on 31 March revenues are expected to be £45m in line with the guidance reconfirmed in April. The board expects revenues for the current financial year to 31 March 2016 will be in
21-Apr-2015 07:40 AM

IDH revenues down

Immunodiagnostic Systems Holdings, a leading solution provider to the clinical laboratory diagnostic market, expects revenues for the year ended 31 March to be around £45m - down from £52m in 2014 but in line with guidance given in September. The decre
02-Apr-2015 09:43 AM

IDS chief executive takes up reins

Immunodiagnostic Systems Holdings has confirmed that Patricio Lacalle has officially taken up his position as chief executive and that Burkhard Wittek will revert to being non-executive chairman with immediate effect. The company says it will provide a
03-Feb-2015 09:01 AM

IDS appoints chief executive

Immunodiagnostic Systems Holdings, a leading producer of manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets, has appointed Patricio Lacalle as chief executive officer. He will join IDS as a d
24-Dec-2014 03:27 PM

CEO of Immunodiagnostic Systems to leave in early January

Immunodiagnostic Systems Holdings has announced that Patrik Dahlen, its chief executive officer, will leave on January 4. Last month it said that Mr Dahlen had given 12 months' notice to leave the company but it has now reached agreement for him to
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t